Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore to Use Swedish Government Grant to Develop NGS Capabilities for Omics Explorer

Premium

Qlucore said this week that it will use a grant from the Swedish government to develop next-generation sequence data analysis capabilities for Omics Explorer — the company's software for analyzing data from gene expression, proteomic, DNA methylation, protein array, and miRNA experiments.

The firm intends to build a new product module for Omics Explorer that will enable fast and interactive analysis of NGS data and will also appeal to a broader audience instead of just bioinformaticians and statisticians. They plan to release the first version of Omics Explorer that includes NGS capabilities next year.

In an email, Carl-Johan Ivarsson, Qlucore's president, told BioInform that although the company is still deciding on what capabilities to incorporate into Omics Explorer, the final product will likely include "new ways of visualizing data" as well as "filters and detection algorithms for a range of biological[ly] relevant questions such as deletions, insertions, translocations, fusion genes [and more]."

He also said that the company opted to extend its existing product rather than develop a separate solution so that customers can use the same tool to analyze different data types.

The grant was provided by Vinnova, the Swedish Governmental Agency for Innovation Systems, which supports small and medium-sized enterprises through its Research and Grow program.

Qlucore declined to disclose details about the exact amount of the grant.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more